Zymeworks

TD COWEN Gives Zymergen a Buy Rating

ZYMEWORKS INC : TD COWEN INITIATES COVERAGE WITH BUY RATING

Susquehanna Fundamental Investments LLC has acquired 97,553 shares of Zymeworks Inc. (NYSE:ZYME) valued at approximately $1.43 million, representing 0.14% ownership. Other investors, including China Universal Asset Management and Sterling Capital Management, have also increased their stakes. Analysts have given Zymeworks a consensus rating of "Moderate Buy" with a price target of $21.00. The stock opened at $13.01, with a market cap of $905.20 million. Insider buying has also been noted, with significant purchases made recently.

Susquehanna Fundamental Investments LLC Purchases New Shares in Zymeworks Inc. (NYSE:ZYME)

Acuta Capital Partners LLC acquired 67,240 shares of Zymeworks Inc. (NYSE:ZYME) for approximately $984,000, making it 1.0% of their portfolio. Other institutional investors also increased their stakes in Zymeworks. Insider transactions included a purchase of 73,953 shares by Director Ecor1 Capital. Zymeworks has a market cap of $896.15 million and a current stock price of $12.88. Analysts have mixed ratings, with a consensus rating of "Moderate Buy" and an average target price of $21.00.

TD COWEN Gives Zymergen a Buy Rating

Summary

Impact Analysis